New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S719

Introduced
1/11/22  

Caption

Requires DOH to study racial aspects of ovarian cancer.

Impact

The expected impact of SB 719 is significant, as it aims to highlight and address potential health disparities in ovarian cancer cases among different racial and ethnic demographics. By researching these disparities, the DOH may provide valuable insights that could influence future healthcare policies and resource allocation aimed at improving health outcomes for underserved groups. This bill may prompt a broader dialogue about racial equity in health services and potentially lead to targeted interventions that enhance care for specific communities.

Summary

Senate Bill 719 mandates the New Jersey Department of Health (DOH) to conduct a focused study on the racial aspects of ovarian cancer. The objective of the study is to explore the differences in ovarian cancer effects, rates, risk factors, symptoms, and outcomes across various racial and ethnic groups. The bill specifically includes but is not limited to groups such as Asian, African-American, Caucasian, Hispanic, Native American, and Pacific Islander women, emphasizing the need for a comprehensive understanding of how ovarian cancer impacts diverse populations differently.

Conclusion

Overall, SB 719 represents a proactive approach in acknowledging and investigating the complexities surrounding ovarian cancer and its varied impact by race. The findings from the mandated study could significantly contribute to public health knowledge and influence future legislative efforts aimed at reducing health disparities. The bill's ability to garner support and funding will likely shape its implementation and effectiveness.

Contention

While the bill appears to be a progressive effort to study important health disparities, there may be contention regarding the allocation of state resources for such studies, as well as discussions about the efficacy of these findings in enacting real change within the healthcare system. Critics might argue about the necessity and urgency of this study in the context of other pressing health initiatives. Furthermore, there could be debates surrounding the methodologies employed in gathering and analyzing data across different racial groups, as well as the implications of the findings once presented to the state legislature.

Companion Bills

NJ A1692

Same As Requires DOH to study racial aspects of ovarian cancer.

Previously Filed As

NJ S327

Requires insurers and SHBP to provide coverage for expenses incurred in screening for ovarian cancer.

NJ SR0394

OVARIAN CANCER AWARENESS MO.

NJ HB633

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

NJ HB0633

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

NJ A06509

Relates to ovarian cancer research; requires biennial reporting on recommendations from the health research and science board on the types of data that would be useful for ovarian cancer researchers.

NJ SR56

Relative to Ovarian Cancer Awareness Month of 2025.

NJ SB518

Health Insurance - Screening for Ovarian Cancer - Required Coverage and Prohibited Cost Sharing

NJ HR1532

National Ovarian Cancer Awareness Month; September 2026; support designation

NJ SB551

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage and Prohibited Cost Sharing

NJ HR775

Supporting the designation of September 2025 as "National Ovarian Cancer Awareness Month".

Similar Bills

No similar bills found.